Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease.

Rebman AW, Aucott JN.

Front Med (Lausanne). 2020 Feb 25;7:57. doi: 10.3389/fmed.2020.00057. eCollection 2020. Review.


The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease.

Fallon BA, Zubcevik N, Bennett C, Doshi S, Rebman AW, Kishon R, Moeller JR, Octavien NR, Aucott JN.

Front Med (Lausanne). 2019 Dec 6;6:283. doi: 10.3389/fmed.2019.00283. eCollection 2019.


Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease.

Zhou Y, Qin S, Sun M, Tang L, Yan X, Kim TK, Caballero J, Glusman G, Brunkow ME, Soloski MJ, Rebman AW, Scavarda C, Cooper D, Omenn GS, Moritz RL, Wormser GP, Price ND, Aucott JN, Hood L.

J Proteome Res. 2020 Jan 3;19(1):346-359. doi: 10.1021/acs.jproteome.9b00569. Epub 2019 Nov 1.


Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.

Mosel MR, Carolan HE, Rebman AW, Castro S, Massire C, Ecker DJ, Soloski MJ, Aucott JN, Eshoo MW.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00237-19. doi: 10.1128/AAC.00237-19. Print 2019 Jul.


Automated detection of erythema migrans and other confounding skin lesions via deep learning.

Burlina PM, Joshi NJ, Ng E, Billings SD, Rebman AW, Aucott JN.

Comput Biol Med. 2019 Feb;105:151-156. doi: 10.1016/j.compbiomed.2018.12.007. Epub 2018 Dec 18.


Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET.

Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES, Rosenthal HB, Reekie TA, Kassiou M, Dannals RF, Soloski MJ, Aucott JN, Pomper MG.

J Neuroinflammation. 2018 Dec 19;15(1):346. doi: 10.1186/s12974-018-1381-4.


Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.

Blum LK, Adamska JZ, Martin DS, Rebman AW, Elliott SE, Cao RRL, Embers ME, Aucott JN, Soloski MJ, Robinson WH.

Front Immunol. 2018 Jul 18;9:1634. doi: 10.3389/fimmu.2018.01634. eCollection 2018.


Incidence of Lyme Disease Diagnosis in a Maryland Medicaid Population, 2004-2011.

Rebman AW, Wang L, Yang T, Marsteller JA, Murphy SME, Uriyo M, Mihm EA, Weinstein ER, Fagan P, Aucott JN.

Am J Epidemiol. 2018 Oct 1;187(10):2202-2209. doi: 10.1093/aje/kwy133.


Cognitive Decline in Post-treatment Lyme Disease Syndrome.

Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):455-465. doi: 10.1093/arclin/acy051.


Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.

Weinstein ER, Rebman AW, Aucott JN, Johnson-Greene D, Bechtold KT.

Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy035.


The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN.

Front Med (Lausanne). 2017 Dec 14;4:224. doi: 10.3389/fmed.2017.00224. eCollection 2017.


Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.


CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.


Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.

Bouquet J, Soloski MJ, Swei A, Cheadle C, Federman S, Billaud JN, Rebman AW, Kabre B, Halpert R, Boorgula M, Aucott JN, Chiu CY.

mBio. 2016 Feb 12;7(1):e00100-16. doi: 10.1128/mBio.00100-16.


Living in Limbo: Contested Narratives of Patients With Chronic Symptoms Following Lyme Disease.

Rebman AW, Aucott JN, Weinstein ER, Bechtold KT, Smith KC, Leonard L.

Qual Health Res. 2017 Mar;27(4):534-546. doi: 10.1177/1049732315619380. Epub 2016 Jul 10.


Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.


Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients.

Rebman AW, Crowder LA, Kirkpatrick A, Aucott JN.

Clin Rheumatol. 2015 Mar;34(3):585-9. doi: 10.1007/s10067-014-2706-z. Epub 2014 Jun 13.


Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease.

Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, Soloski MJ, Ecker DJ, Schutzer SE, Aucott JN.

PLoS One. 2012;7(5):e36825. doi: 10.1371/journal.pone.0036825. Epub 2012 May 8.


Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Aucott JN, Rebman AW, Crowder LA, Kortte KB.

Qual Life Res. 2013 Feb;22(1):75-84.

Supplemental Content

Loading ...
Support Center